Howard Hughes Medical Institute’s American Express AXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-116
Closed -$42.9K 75
2025
Q4
$42.9K Sell
116
-1
-0.9% -$358 0.02% 51
2025
Q3
$38.9K Sell
117
-2
-2% -$636 0.02% 55
2025
Q2
$38K Buy
+119
New +$33.5K 0.02% 55
2015
Q3
Sell
-4,352
Closed -$338K 158
2015
Q2
$338K Buy
+4,352
New +$345K 0.07% 110
2015
Q1
Sell
-65,000
Closed -$6.05M 165
2014
Q4
$6.05M Hold
65,000
1.62% 16
2014
Q3
$5.69M Hold
65,000
1.27% 20
2014
Q2
$6.17M Sell
65,000
-16,736
-20% -$1.51M 1.04% 18
2014
Q1
$7.36M Sell
81,736
-541
-0.7% -$48.3K 1.04% 10
2013
Q4
$7.46M Buy
82,277
+933
+1% +$76.6K 1.13% 13
2013
Q3
$6.14M Buy
81,344
+1,344
+2% +$101K 0.94% 18
2013
Q2
$5.98M Buy
+80,000
New +$5.69M 1.97% 19

Other funds holding AXP

Howard Hughes Medical Institute's AXP Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of American Express (AXP) in Q1 2026, closing a stake of 116 shares — an estimated $42.9K sold.

Howard Hughes Medical Institute first reported a position in AXP in Q2 2013 and held it in 11 quarters. The position peaked at $7.46M in Q4 2013. 2,888 funds tracked by Wall St. Rank hold AXP as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining American Express position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 116 American Express shares in Q1 2026, an estimated $42.9K.
  • Howard Hughes Medical Institute first reported a position in American Express in Q2 2013 and held it in 11 quarters.
  • Howard Hughes Medical Institute's American Express position peaked at $7.46M in Q4 2013.
  • 2,888 funds tracked by Wall St. Rank held American Express as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.